183 related articles for article (PubMed ID: 35939144)
1. Exploring the pathological relationships between adamantinomatous craniopharyngioma and contiguous structures with tumor origin.
Li S; Wu B; Xiao Y; Wu J; Yang L; Yang C; Huang Z; Pan C; Li M; Yang Y; Tang B; Xie S; Wu X; Zheng S; Wang C; Hong T
J Neurooncol; 2022 Sep; 159(2):485-497. PubMed ID: 35939144
[TBL] [Abstract][Full Text] [Related]
2. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
[TBL] [Abstract][Full Text] [Related]
3. A novel endoscopic classification for craniopharyngioma based on its origin.
Tang B; Xie SH; Xiao LM; Huang GL; Wang ZG; Yang L; Yang XY; Xu S; Chen YY; Ji YQ; Zeng EM; Hong T
Sci Rep; 2018 Jul; 8(1):10215. PubMed ID: 29977006
[TBL] [Abstract][Full Text] [Related]
4. Craniopharyngiomas primarily affecting the hypothalamus.
Pascual JM; Prieto R; Rosdolsky M
Handb Clin Neurol; 2021; 181():75-115. PubMed ID: 34238481
[TBL] [Abstract][Full Text] [Related]
5. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
Pascual JM; Prieto R; Barrios L
J Neurosurg; 2018 Oct; 131(3):949-963. PubMed ID: 30497204
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors.
Prieto R; Pascual JM; Rosdolsky M; Castro-Dufourny I; Carrasco R; Strauss S; Barrios L
Neurosurg Focus; 2016 Dec; 41(6):E13. PubMed ID: 27903121
[TBL] [Abstract][Full Text] [Related]
7. The infundibulo-tuberal syndrome caused by craniopharyngiomas: clinicopathological evidence from an historical French cohort (1705-1973).
Castro-Dufourny I; Carrasco R; Prieto R; Barrios L; Pascual JM
Pituitary; 2015 Oct; 18(5):642-57. PubMed ID: 25527245
[TBL] [Abstract][Full Text] [Related]
8. The eagle sign: a new preoperative MRI-based tool for predicting topographic correlation between craniopharyngioma and hypothalamus.
Li S; Yang L; Tong Z; Wu B; Tang B; Xie S; Li M; Zhou L; Ouyang C; Wu X; Yang Y; Wang C; Hong T
J Cancer Res Clin Oncol; 2022 May; 148(5):1235-1249. PubMed ID: 34625840
[TBL] [Abstract][Full Text] [Related]
9. Craniopharyngioma treatment: an updated summary of important clinicopathological concepts.
Prieto R; Rosdolsky M; Hofecker V; Barrios L; Pascual JM
Expert Rev Endocrinol Metab; 2020 Jul; 15(4):261-282. PubMed ID: 32615875
[TBL] [Abstract][Full Text] [Related]
10. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
Esheba GE; Hassan AA
J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
[TBL] [Abstract][Full Text] [Related]
11. Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases.
Prieto R; Barrios L; Pascual JM
Neurosurg Rev; 2022 Feb; 45(1):375-394. PubMed ID: 34448081
[TBL] [Abstract][Full Text] [Related]
12. Correlations between the expression of molecules in the TGF-β signaling pathway and clinical factors in adamantinomatous craniopharyngiomas.
Jin L; Cai K; Wu W; Xiao Y; Qiao N; Liu F; Ru S; Cao L; Zhu H; Bai J; Liu C; Li C; Zhao P; Zhang Y; Gui S
Front Endocrinol (Lausanne); 2023; 14():1167776. PubMed ID: 37854185
[TBL] [Abstract][Full Text] [Related]
13. Infundibulo-tuberal or not strictly intraventricular craniopharyngioma: evidence for a major topographical category.
Pascual JM; Prieto R; Carrasco R
Acta Neurochir (Wien); 2011 Dec; 153(12):2403-25; discussion 2426. PubMed ID: 21918833
[TBL] [Abstract][Full Text] [Related]
14. Preoperative Assessment of Craniopharyngioma Adherence: Magnetic Resonance Imaging Findings Correlated with the Severity of Tumor Attachment to the Hypothalamus.
Prieto R; Pascual JM; Rosdolsky M; Barrios L
World Neurosurg; 2018 Feb; 110():e404-e426. PubMed ID: 29138072
[TBL] [Abstract][Full Text] [Related]
15. Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.
Cao J; Lin JP; Yang LX; Chen K; Huang ZS
Br J Neurosurg; 2010 Jun; 24(3):249-56. PubMed ID: 20128632
[TBL] [Abstract][Full Text] [Related]
16. Histopathology and molecular characterisation of intrauterine-diagnosed congenital craniopharyngioma.
Scagliotti V; Avagliano L; Gualtieri A; Graziola F; Doi P; Chalker J; Righini A; Korbonits M; Bulfamante G; Jacques TS; Massa V; Gaston-Massuet C
Pituitary; 2016 Feb; 19(1):50-6. PubMed ID: 26350256
[TBL] [Abstract][Full Text] [Related]
17. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
18. Joseph Engel (1816-1899), author of a meaningful dissertation on tumors of the pituitary infundibulum: his report on the oldest preserved whole craniopharyngioma specimen.
Pascual JM; Prieto R; Rosdolsky M; Hofecker V; Strauss S; Winter E; Ulrich W
Virchows Arch; 2020 May; 476(5):773-782. PubMed ID: 31511968
[TBL] [Abstract][Full Text] [Related]
19. Histological findings at the boundary of craniopharyngiomas.
Kawamata T; Kubo O; Hori T
Brain Tumor Pathol; 2005; 22(2):75-8. PubMed ID: 18095108
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma.
Martinez-Barbera JP; Andoniadou CL
Stem Cells; 2016 Feb; 34(2):268-76. PubMed ID: 26763580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
